Recent developments and future perspectives in the diagnosis and treatment of tuberculosis

Symposium
Chairs: G. Bothamley (London, United Kingdom), F. Varaine (Paris, France)
Aims: to discuss the new techniques to diagnose tuberculosis in children and HIV-positive patients , to present the growing body of evidence supporting the use of new anti-tuberculosis drugs, including results of the MSF-sponsored endTB observational cohort and to provide an overview of ongoing and future clinical trials of new treatment regimens for M/XDR-TB, including the MSF-sponsored Phase III trials endTB and TB-PRACTECAL.

Innovative tools for diagnosis and prevention of paediatric tuberculosis M. Bonnet (Genève, Switzerland)
Integration of care pathways for HIV-tuberculosis coinfection: a public health agenda F. Blanc (Nantes Cedex 1, France)
Efficacy and safety of new drugs for M/XDR-TB: what have we learned from observational studies? C. Hewison (Paris, France)
Clinical trial landscape for M/XDR-TB: current evidence and future perspectives C. Mitnick (Boston, United States of America)